Evidence map›Paper›PMID 37633197›Full record

ArticleInternational journal of surgery case reports2023

Diagnostic utility of EUS-FNA in distinguishing hepatocellular carcinoma from gastric submucosal tumor: A case report.

Naoya Kobayashi, Hiroshi Yoshida, Nanako Fujikawa, Shingo Yoshimachi, Atsushi Kohyama, Shinya Kawaguchi

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naoya KobayashiDepartment of Surgery, Iwaki City Medical Center, 16 Kusehara, Uchigomimayamachi, Iwaki-shi, Fukushima 973-8555, Japan. Electronic address: naoya_712@icloud.com.
Hiroshi YoshidaDepartment of Surgery, Iwaki City Medical Center, 16 Kusehara, Uchigomimayamachi, Iwaki-shi, Fukushima 973-8555, Japan.
Nanako FujikawaDepartment of Surgery, Iwaki City Medical Center, 16 Kusehara, Uchigomimayamachi, Iwaki-shi, Fukushima 973-8555, Japan.
Shingo YoshimachiDepartment of Surgery, Iwaki City Medical Center, 16 Kusehara, Uchigomimayamachi, Iwaki-shi, Fukushima 973-8555, Japan.
Atsushi KohyamaDepartment of Surgery, Iwaki City Medical Center, 16 Kusehara, Uchigomimayamachi, Iwaki-shi, Fukushima 973-8555, Japan.
Shinya KawaguchiDepartment of Surgery, Iwaki City Medical Center, 16 Kusehara, Uchigomimayamachi, Iwaki-shi, Fukushima 973-8555, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and importanceExtrahepatically growing hepatocellular carcinoma (HCC) account for only 0.3 %-2.4 % of all hepatocellular carcinoma cases. We present the rare case of a patient in whom endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was used to distinguish an extrahepatically growing HCC from a gastric submucosal tumor. CASE PRESENTATION: The patient was a 44-year-old man who underwent an esophagogastroduodenoscopy (EGD) and was found to have a submucosal tumor (SMT). A gastrointestinal stromal tumor was suspected. Computed tomography (CT) showed an unclear connecting between the tumor and the liver. On immunohistochemical analysis, the tumor cells were positive for CK7, PIVKA-II, and glypican-3, and negative for C-kit. Based on these findings, HCC was suspected, and ethoxybenzyl diethylenetriamine-enhanced magnetic resonance imaging (EOB-MRI) was performed. EOB-MRI revealed the connecting of the tumor and the liver. Thus, the patient was diagnosed as having an extrahepatically protruding HCC, and laparoscopic S2 partial hepatectomy was performed. Pathologically, the tumor was identified as a moderately differentiated HCC. According to the 8th edition of the UICC TNM Classification, the tumor was classified as T1bN0M0 and stage IB. CLINICAL DISCUSSION: Owing to its rarity, the diagnosis of an extrahepatically protruding HCC is often difficult when the differentiation of a gastric SMT and HCC is unclear on CT. As in this case, if an HCC is also differentiated on hematoxylin and eosin staining after EUS-FNA, immunohistochemistry findings can help in the diagnosis.

conclusionThe findings show that EUS-FNA could be helpful for diagnosis when an HCC needs to be differentiated from a gastric SMT.

Indexed as

Endoscopic ultrasound-guided fine-needle aspirationExtrahepatically growing hepatocellular carcinomaGastric submucosal tumor

Identifiers

PMID37633197
PMCPMC10509792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.